<DOC>
	<DOCNO>NCT01755169</DOCNO>
	<brief_summary>This study design select tolerable dose oral ketamine child chronic pain . Children give either placebo one three dosages oral ketamine 2 week . The dosage tolerable select study .</brief_summary>
	<brief_title>Ketamine Chronic Kid 's ( KiCK ) Pain</brief_title>
	<detailed_description>Children chronic pain randomize one four arm ( three study drug arm , one placebo arm ) randomize , double-blinded fashion . Children treat 2 week monitor additional 12 week . Study participation total 14 week .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Subject , parent , guardian willing able give inform consent NRS pain past 24 hour &gt; 4 baseline Chronic pain , present &gt; 3 month , persist longer normal underlying diagnosis Chronic pain related physiologic diagnosis include limited : cancer , rheumatologic disease , sickle cell anemia , cystic fibrosis , pancreatitis , neuromuscular disease ( e.g . Duchenne muscular dystrophy ) Able tolerate cooperate neurocognitive assessment Age 820 year old If know suspected drug addiction Uncontrolled psychiatric disorder depression , schizophrenia , bipolar disorder Uncontrolled hypertension Known liver disease elevation AST ALT great 3 time upper limit normal . Previous intolerance allergic reaction ketamine Pregnancy Use CYP3A4 inhibitor inducer within 2week period prior study drug administration within 5 halflives respective medication , whichever longer , study conclusion . Consumption grapefruit grapefruit product least 2 week prior study drug administration study conclusion .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>Child</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Ketamine</keyword>
</DOC>